Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Triggiani

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 yearsCem Akin, Vito Sabato, Jason Gotlib, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSSAnne-Lise Courbis, Ruth Brigid Murray, Sylvie Arnavielhe, et al.
Blood Advances|January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER studyJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on MastocytosisJohannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical ImmunologyKarin Hartmann, Luis Escribano, Clive Grattan, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 yearsCem Akin, Vito Sabato, Jason Gotlib, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSSAnne-Lise Courbis, Ruth Brigid Murray, Sylvie Arnavielhe, et al.
Blood Advances|January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER studyJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on MastocytosisJohannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical ImmunologyKarin Hartmann, Luis Escribano, Clive Grattan, et al.
Pageof 15